Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
312.36
-4.25 (-1.34%)
At close: Mar 28, 2025, 4:00 PM
311.26
-1.10 (-0.35%)
Pre-market: Mar 31, 2025, 8:42 AM EDT
Medpace Holdings Revenue
In the year 2024, Medpace Holdings had annual revenue of $2.11B with 11.84% growth. Medpace Holdings had revenue of $536.59M in the quarter ending December 31, 2024, with 7.66% growth.
Revenue (ttm)
$2.11B
Revenue Growth
+11.84%
P/S Ratio
4.58
Revenue / Employee
$357,467
Employees
5,900
Market Cap
9.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.11B | 223.21M | 11.84% |
Dec 31, 2023 | 1.89B | 425.85M | 29.17% |
Dec 31, 2022 | 1.46B | 317.62M | 27.80% |
Dec 31, 2021 | 1.14B | 216.45M | 23.38% |
Dec 31, 2020 | 925.93M | 64.96M | 7.54% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
MEDP News
- 12 days ago - Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025 - Business Wire
- 4 weeks ago - The Schall Law Firm Invites Shareholders With Losses In Medpace Holdings, Inc. To Join A Securities Fraud Investigation - Accesswire
- 6 weeks ago - Medpace Holdings, Inc. (MEDP) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results - Business Wire
- 7 weeks ago - Medpace: Impressive Revenue Growth, High ROE Values, And High Growth Potential - Seeking Alpha
- 2 months ago - The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Medpace Holdings, Inc. For Securities Fraud - Accesswire
- 2 months ago - Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 2 months ago - Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm - Accesswire